KCNE2的多功能作用2:从心律失常到多系统性疾病
Ming Song1, Yixin Zhuge1, Yuqi Tu1
1Department of Pathophysiology, Medical School, Shenzhen University, Shenzhen 518060, China.
Cells
|September 14, 2024
概括
对于心脏和肠道功能至关重要的KCNE2蛋白在各种生理过程中发挥作用. KCNE2基因突变与多系统性疾病有关,影响心血管,神经和代谢健康.
科学领域:
- 生物化学 生物化学
- 生理学 生理学 生理学
- 遗传学 是一个遗传学.
背景情况:
- KCNE2蛋白,也称为MinK相关蛋白1 (MiRP1),是由KCNE2基因编码的.
- 它主要表达在心脏的副心脏和胃粘膜中,在甲状腺和胰腺等其他组织中表达的水平较低.
- KCNE2表现出伴侣的乱交,与各种离子通道和蛋白质相互作用.
研究的目的:
- 提供KCNE2在维持生物体平衡中的生理功能概述.
- 探索KCNE2功能障碍在多系统疾病中的病理生理后果.
- 突出了解KCNE2在健康和疾病中的作用的进展.
主要方法:
- 文献综述和对KCNE现有研究的综合2.
- 分析KCNE2在不同器官系统中的生理作用.
- 检查KCNE2基因突变/异常表达与疾病发病之间的联系.
主要成果:
- KCNE2调节关键的离子通道 (和),这对于心脏动作潜力的再极化至关重要.
- 它调节表皮中的分泌过程,包括胃酸分泌和甲状腺激素合成.
- 异常的KCNE2表达或KCNE2基因突变与心血管,神经,代谢和多系统性疾病有关.
结论:
- KCNE2是一种具有多种生理作用的重要蛋白质,对维持平衡至关重要.
- KCNE2的失调与多种多系统性疾病的频谱有关.
- 对KCNE2的进一步研究对于理解和潜在治疗这些疾病至关重要.
相关概念视频
Mechanism of Cardiac Arrhythmias
900
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
900
Electrophysiology of Normal Cardiac Rhythm
2.3K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
2.3K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
719
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
719
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Voltage-gated Ion Channels
8.1K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.1K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
933
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
933


